Gastrointestinal oncologist and health services researcher Ryan Nipp discusses new research about how muscle quality correlates with cancer outcomes.

by Ashley P. Taylor

A study finds that many people with solid tumors mount an antibody response following COVID-19 vaccination, and the Food and Drug Administration approves the first targeted therapy for a rare lung cancer subtype.

by Kate Yandell

Testing for hereditary mutations is increasingly recommended for people with cancer, but recommendations do not always translate into access to testing and appropriate counseling.

by Kate Yandell

The U.S. Preventive Services Task Force lowers its recommended age to begin colorectal cancer screening to 45, and a major multiple myeloma study begins in Iceland.

by Bradley Jones

Researchers report disappointing results about ovarian cancer screening, and cancer patients with impaired immune function feel uncertain about protection offered by COVID-19 vaccination.

by Marci A. Landsmann

Advances in screening and treatment mean there are more cancer survivors than ever, but survivors who struggle to work can face difficulty getting disability payments.

by Jen Tota McGivney

At a patient advocate event, researchers discussed how to extend the benefits of immunotherapy to more people.

by Kevin McLaughlin

A Food and Drug Administration panel recommends withdrawing approvals for two treatment indications for immunotherapy drugs, and the U.S. Preventive Services Task Force recommend against vitamin E and beta-carotene for cancer prevention.

by Kevin McLaughlin

Testing children with cancer for hereditary mutations could impact their treatment and provide information relevant to other family members.

by Marcus A. Banks